Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Valsartan-Containing Products – Recall Update
August 22, 2018 - The FDA announced an update to the voluntary, consumer-level recall of valsartan-containing products due to the presence of an impurity, N-nitrosodimethylamine (NDMA).
